Moomoo AI 已提取核心信息
Intuitive Surgical, Inc. (Intuitive) released unaudited preliminary financial results for the fourth quarter and full year of 2023 on January 9, 2024. The report highlighted a 21% growth in worldwide da Vinci procedures in Q4 2023 compared to Q4 2022, and a 22% increase for the full year. The company placed 415 da Vinci surgical systems in Q4, marking a 12% increase from the previous year, and 1,370 systems in 2023, up by 8% from 2022. Revenue for Q4 2023 is estimated at approximately $1.93 billion, a 17% rise from Q4 2022, with full-year revenue expected to be around $7.12 billion, representing a 14% increase. The growth in procedures and revenue was attributed to the adoption of the company's platforms and increased procedure volumes, particularly in U.S. general surgery and international cancer procedures. The report also noted a recovery in procedure...Show More
Intuitive Surgical, Inc. (Intuitive) released unaudited preliminary financial results for the fourth quarter and full year of 2023 on January 9, 2024. The report highlighted a 21% growth in worldwide da Vinci procedures in Q4 2023 compared to Q4 2022, and a 22% increase for the full year. The company placed 415 da Vinci surgical systems in Q4, marking a 12% increase from the previous year, and 1,370 systems in 2023, up by 8% from 2022. Revenue for Q4 2023 is estimated at approximately $1.93 billion, a 17% rise from Q4 2022, with full-year revenue expected to be around $7.12 billion, representing a 14% increase. The growth in procedures and revenue was attributed to the adoption of the company's platforms and increased procedure volumes, particularly in U.S. general surgery and international cancer procedures. The report also noted a recovery in procedure volumes following early 2023 COVID-19 resurgences in China. Intuitive's CEO, Gary Guthart, expressed satisfaction with the platform adoption and the company's focus on supporting customers' pursuit of the quadruple aim in acute interventions. The full financial results will be discussed in more detail during a conference call on January 23, 2024, following the company's presentation at the J.P. Morgan Healthcare Conference on January 10, 2024.
Intuitive Surgical, Inc.（Intuitive）于2024年1月9日发布了2023年第四季度和全年未经审计的初步财务业绩。该报告强调，与2022年第四季度相比，全球达芬奇手术在2023年第四季度增长了21％，全年增长了22％。该公司在第四季度安装了415套达芬奇手术系统，比上年增长了12％；在2023年安装了1,370套系统，比2022年增长了8％。2023年第四季度的收入估计约为19.3亿美元，较2022年第四季度增长17％，全年收入预计约为71.2亿美元，增长14％。手术和收入的增长归因于公司平台的采用和手术量的增加，尤其是在美国普通外科和国际癌症手术中。该报告还指出...展开全部
Intuitive Surgical, Inc.（Intuitive）于2024年1月9日发布了2023年第四季度和全年未经审计的初步财务业绩。该报告强调，与2022年第四季度相比，全球达芬奇手术在2023年第四季度增长了21％，全年增长了22％。该公司在第四季度安装了415套达芬奇手术系统，比上年增长了12％；在2023年安装了1,370套系统，比2022年增长了8％。2023年第四季度的收入估计约为19.3亿美元，较2022年第四季度增长17％，全年收入预计约为71.2亿美元，增长14％。手术和收入的增长归因于公司平台的采用和手术量的增加，尤其是在美国普通外科和国际癌症手术中。该报告还指出，在 2023 年初 COVID-19 在中国卷土重来之后，手术量有所回升。Intuitive的首席执行官Gary Guthart对该平台的采用以及公司专注于支持客户在急性干预中实现四重目标表示满意。继公司于2024年1月10日在摩根大通医疗保健会议上发表演讲之后，将在2024年1月23日的电话会议上更详细地讨论完整的财务业绩。
有用
没用